Brind.

Leerink partners maintained a Buy rating on Ardelyx on June 25, 2025.

1 report, 0 independent Updated Jun 25

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

Ardelyx (United States)Leerink partners

How it developed

Newest first. Tap a step to see who reported it.

Jun 27Analyst firm reaffirmed rating on Ardelyx stock, while an insider sold company shares.Sub-event
Jun 25Leerink partners maintained a Buy rating on Ardelyx.

Keep exploring

The entities involved

Ardelyx (United States)
company in Fremont, United States
- BlackRock is the largest shareholder in a company involving Axos Financial as of August 2, 2025.Sun 09:02
Leerink partners
U.S. investment bank
- Analyst firm set price targets for Leerink partners' client, Twist Bioscience, on June 26, 2026. Concurrently, the CEO sold shares due to tax withholding obligations.Mon 08:52
- A filing required by the SEC concerning McKesson Corporation shares, accompanied by analyst commentary.Sun 22:38

Coverage

Newest first; wire copies grouped

Jun 25Unknown outlet